Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Journal article

Kaufmann M. et al, (2022), Nature Neuroscience

The immunology of multiple sclerosis.

Journal article

Attfield KE. et al, (2022), Nat Rev Immunol

MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19.

Journal article

Francis A. et al, (2022), Lancet Neurol, 21, 217 - 218

Inflammation-related plasma and CSF biomarkers for multiple sclerosis.

Journal article

Huang J. et al, (2020), Proc Natl Acad Sci U S A, 117, 12952 - 12960

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Journal article

Faergeman SL. et al, (2020), Cell Death Dis, 11

Identifying cross-disease components of genetic risk across hospital data in the UK Biobank.

Journal article

Cortes A. et al, (2020), Nat Genet, 52, 126 - 134

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.

Journal article

du Pré MF. et al, (2019), The Journal of experimental medicine

HLA variation and disease

Journal article

Dendrou CA. et al, (2018), Nature Reviews Immunology, 18, 325 - 339

The Human Cell Atlas

Journal article

Regev A. et al, (2017), eLife, 6

Immunomodulation in multiple sclerosis: promises and pitfalls

Journal article

Dendrou CA. and Fugger L., (2017), Current Opinion in Immunology, 49, 37 - 43

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

Journal article

Cortes A. et al, (2017), Nature Genetics, 49, 1311 - 1318

Structural and regulatory diversity shape HLA-C protein expression levels

Journal article

Kaur G. et al, (2017), Nature Communications, 8

Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells

Journal article

Ooi JD. et al, (2017), Nature, 545, 243 - 247

Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy

Journal article

Haghikia A. et al, (2017), The Lancet Neurology, 16, 104 - 106

Neuroinflammation — using big data to inform clinical practice

Journal article

Dendrou CA. et al, (2016), Nature Reviews Neurology, 12, 685 - 698

Load More